The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Parkinson’s UK award a multi-million dollar grant to ...

The company announced that it has partnered with Adena Health and The Ohio State University Health Plan Solutions. Digital ...

PrimeRX announced the launch of a new platform aimed at pharmacies named PrimeRX MARKET. 1 This platform will provide users ...

Funding from the Biomedical Advanced Research and Development Authority (BARDA) is expected to support the late-stage ...

Kisunla is the first amyloid plaque-targeting therapy that allows for stopping treatment upon plaque removal, company says.

NeuroSense announced further data from its PARADIGM Phase 2b study. 1 The new data was derived from a 12-month analysis of ...

Robert A. Michael has assumed the role of CEO at AbbVie. 1 He has replaced Richard A. Gonzalez, who stepped down from the ...

How pharmaceutical companies can utilize AI at key stages of the treatment journey to enhance patient-centric engagement by ...

Approval of both NRX-101 and NRX-100 could potentially yield more than $150 in revenue per NRXP share in the near term, ...

Reportedly, the liquid formulation of Tepylute eliminates the need for complex and time-consuming reconstitution, providing ...

After years of collaborating with hospitals, Magnolia Medical has launched a new digital platform designed to prevent sepsis ...

Ohtuvayre is the first inhaled product with a novel mechanism of action for chronic obstructive pulmonary disease to be ...